With the production of these urgently needed masks and garments, we’re working to rapidly build a supply of protective equipment requested by medical professionals and government leaders to help contain the expansion of the Covid-19 virus.

VIDALIA, La. (PRWEB)
May 07, 2020

Vidalia Mills, the leading North American maker of yarns and denim fabrics, and Keep it Here, a major Los Angeles-based manufacturing of t-shirts, jeans, and other clothing, have announced a new joint-venture to manufacture and distribute surgical masks, gowns, and face masks to assist medical professionals in limiting the spread of the Covid-19 virus.

Vidalia Mills has purchased one automated surgical grade mask-making machine, along with two automatic N95 high-protection mask-making machines, which will be installed within the next 90 days in a new cleanroom facility under construction at the Vidalia Mills plant and will utilize nonwoven and other advanced textile materials. The machines can produce up to 100 million units annually.

Additionally, Vidalia Mills has deployed twenty high-speed weaving looms to make lightweight cotton fabrics for the production of medical gowns and consumer face masks to be cut and sewn at Keep it Here in Los Angeles. In turn, the materials will be anti-viral and anti-microbial infused, and made with BASF’s e3® sustainable cotton fabrics.

In making the announcement, Vidalia Mills CEO, Dan Feibus, said, “With the production of these urgently needed masks and garments, we’re working to rapidly build a supply of protective equipment requested by medical professionals and government leaders to help contain the expansion of the Covid-19 virus.”

Patrick Stewart, President of Keep it Here, added, “With our highly trained team, we are able rapidly to design and manufacture products. Because of our manufacturing capabilities, we will be able to make a substantial supply of cotton surgical gowns and consumer face masks to help our country in its hour of need.”

Keep it Here (KIH) is a subsidiary of Omniverse Group. This diversified development company has hired Dr. Pietro D. Marghella, an expert in medical and public health emergencies, to oversee the medical requirements of the production at Vidalia and KIH.

Marghella is an accomplished medical professional and former government and military official. He said of the new joint-venture, “I am pleased to work with the teams at KIH and Vidalia to get production ramped quickly by providing sound medical advice to make high-quality products for the medical community and public at large.”

Commenting on Vidalia’s use of BASF’s e3 sustainable cotton for the production of surgical gowns and face masks, Jennifer Crumpler, Director of the e3 sustainable cotton program said, “BASF is pleased to play a role in supplying versatile cotton grown by farmers throughout the United States for much-needed medical equipment. We are proud that our agricultural community is able to assist healthcare workers and citizens with gowns and face masks made from sustainable cotton during this unprecedented time.”

###

Contacts:

Dan Feibus, CEO, Vidalia Mills            

Email: d.feibus@vidaliamills.com        

Patrick Stewart

Email: p.stewart@k2ominiverse.com

http://www.omniverse-group.com

Jennifer Crumpler, Director of e3 Program

Email: Jennifer.gasque-crumpler@basf.com

Share article on social media or email:

Edens Garden Hand Sanitizer Launch

By formulating and offering hand sanitizer, we hope to alleviate some of the stress and pressure that the global shortage had caused and provide a vital product to individuals and families looking for peace of mind.

SAN CLEMENTE, Calif. (PRWEB)
May 07, 2020

Edens Garden is excited to announce the launch of unscented Hand Sanitizer Spray, adding to its high-quality product lineup. As a massive hand sanitizer shortage hit worldwide, the essential oil company quickly pooled its resources to help the community by providing a safe and effective hand sanitizer.

“At Edens Garden, we believe it is our responsibility to do our best to support and inspire our community in any way we can,” said Grace Martin, Edens Garden’s Founder and CEO. “By formulating and offering hand sanitizer, we hope to alleviate some of the stress and pressure that the global shortage had caused and provide a vital product to individuals and families looking for peace of mind.”.

Killing up to 99.9% of common germs, the unscented Hand Sanitizer Spray is formulated in compliance with strict FDA standards and is registered with the agency. Its 80% alcohol content easily defends and protects. To use, simply spray directly onto hands and rub thoroughly until dry.

The CDC recommends using soap and water whenever possible to wash your hands. Edens Garden also offers a line of natural, essential oil bar soaps, but recommends the use of hand sanitizer when grocery shopping, running or errands or whenever hand washing is not readily available.

For Edens Garden customers looking for an essential oil blend to diffuse while disinfecting their hands, the brand recommends Fighting Five, Guardian, Immunity, or Healthy Hero.

About Edens Garden

Edens Garden was formed in 2009 with the intent to provide high-quality, pure essential oils at affordable prices. Since that time, the online company has grown to include a large variety of single oils, synergy blends, carrier oils, body oils, natural bar soap, salt soaks, and perfumes. To find out more about Edens Garden visit edensgarden.com or follow Edens Garden on Facebook, Instagram, and Twitter.

Share article on social media or email:

SMILE can provide a great platform for those who want to learn how to enhance their facial appearance and maintain a beautiful facial appearance now and in the future

BEVERLY HILLS, Calif. (PRWEB)
May 07, 2020

Dr. Babak Azizzadeh, Chairman and Director of the CENTER for Advanced Facial Plastic Surgery in Los Angeles and a globally recognized facial plastic and reconstructive surgeon, has launched the SMILE podcast. With SMILE, Dr. Azizzadeh shares his unique and holistic perspective on a wide range of beauty, health, and wellness topics.

SMILE features industry insights from Dr. Azizzadeh and other experts. Listeners can use SMILE to discover new ways to improve their overall health. Plus, SMILE experts provide tips, recommendations, and suggestions to help listeners get the best results from their current beauty, health, and wellness regimen — or develop and start using a new one.

The first three SMILE episodes come during the coronavirus (COVID-19) pandemic, which has made it exceedingly difficult for healthcare practitioners and their patients to connect. Each episode focuses on a different aspect of the pandemic’s impact on the beauty, health, and wellness community:

Episode 1 — Coronavirus 101: Dr. C. Andrew Schroeder, formerly the Clinical Chief of Pulmonary and Critical Care Medicine at Cedars-Sinai Medical Center and a clinical instructor of medicine at the UCLA David Geffen School of Medicine, takes an in-depth look at the coronavirus crisis and its global ramifications.

Episode 2 — Coronavirus and the Nose: Ear, nose, throat, head, and neck expert Dr. Babak Larian of the CENTER for Advanced Parathyroid Surgery in Los Angeles discusses the coronavirus’ impact on ear, nose, and throat (ENT) surgeons.

Episode 3 — Coronavirus and Your Teeth: Dr. Katrin Azizzadeh, a board-certified family dentist in the Encino, California area who has comprehensive experience in non-aggressive cosmetic and general dentistry, provides tips to help people manage their dental issues during the coronavirus pandemic.

Millions of people undergo facial plastic and reconstructive surgery each year, and Dr. Azizzadeh works with patients to help them quickly and safely revitalize their facial features. Future SMILE podcast episodes will explore a variety of beauty, health, and wellness topics, as well as offer insights to help people achieve a balanced, natural-looking facial appearance.

“I have a simple goal with SMILE: to bring a smile to the face of each listener,” Dr. Azizzadeh says. “By sharing my insights into beauty, health, and wellness and encouraging other experts in these areas to do the same, SMILE can provide a great platform for those who want to learn how to enhance their facial appearance and maintain a beautiful facial appearance now and in the future.”

The first three SMILE episodes are available here. In addition, SMILE episodes are available on Spotify, SoundCloud, Apple, and YouTube.

For more on Dr. Azizzadeh and the CENTER for Advanced Facial Plastic Surgery, visit http://www.facialplasticsbh.com.

About Dr. Babak Azizzadeh and the CENTER for Advanced Facial Plastic Surgery:

Dr. Babak Azizzadeh, Chairman and Director of the CENTER for Advanced Facial Plastic Surgery, is one of the leading international experts in facial plastic surgery. His expertise in cosmetic and reconstructive plastic surgery has made him one of the most sought-after physicians. Dr. Azizzadeh’s client list includes not only celebrities, executives, physicians and dignitaries from around the world, but also amazing people from all walks of life. He has been featured in The Oprah Winfrey Show, People Magazine, New York Times, Discovery Health, Los Angeles Times, Beverly Hills Courier and numerous other media outlets for his expertise in facial plastic surgery. Dr. Azizzadeh is one of a select group of surgeons who are double board-certified by the American Board of Facial Plastic and Reconstructive Surgery as well as the American Board of Otolaryngology-Head and Neck Surgery. His plastic surgery colleagues have consistently chosen him as one of the Top Doctors in Beverly Hills, CA. For more information, please visit https://www.facialplasticsbh.com/

Media Contact: Chloe, CENTER for Advanced Facial Plastic Surgery, 310-657-2203, chloe@facialplasticsbh.com

Share article on social media or email:

“We are proud to name Dr. Amar Raval as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerso

PLEASANTON, Calif. (PRWEB)
May 07, 2020

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Amar Raval M.D., Advanced Urology Institute in Palm Harbor, FL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Raval has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are proud to name Dr. Amar Raval as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “The UroLift System is a safe and effective treatment that allows physicians to treat men in-office under local anesthesia, so they can experience lasting symptom relief within days after receiving treatment.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Xtalks Life Science Webinars

TORONTO, Ontario (PRWEB)
May 07, 2020

Voltage-gated sodium channels (Nav) are integral in almost all aspects of human physiology, including cardiac and muscle function and pain perception. In this webinar, peptide inhibitors derived from venomous toxins will be explored.

The sodium channel subtype Nav1.7 has been genetically validated to be involved in nociception. Peptide toxins isolated from venomous creatures are potent inhibitors of human voltage-gated sodium channels, with venom peptides selective against Nav1.7 showing great potential as therapeutic pain relief agents. They function to inhibit Nav activity by blocking the pore domain (pore blockers) or by binding to the membrane-embedded voltage sensor domain of the sodium channel (gating-modifier toxins).

However, despite intensive research efforts into Nav1.7 inhibitors, there has been little in the way of translation, likely due to our lack of understanding on how to achieve subtype selectivity, completely inhibit Nav1.7 and how to move from effective in vitro to in vivo inhibitors.

In this webinar, delineating the mechanism of action behind venom peptide inhibition of voltage-gated sodium channels will be presented. This will include discussion on engineering peptides to achieve subtype specificity and complete inhibition of specific sodium channels to unlock the potential of potent venom peptides as therapeutic leads for the treatment of pain.

Join Christina I. Schroeder, Stadtman Investigator, National Cancer Institute, National Institutes of Health in a live webinar on Friday, May 22, 2020 at 10am EDT (3pm BST/UK).

For more information or to register for this event, visit Venom Peptides: Rethinking Voltage-Gated Sodium Channel Inhibition.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: